Australia's Tryptamine Therapeutic falls on discounted placement

Entropy Neurodynamics

05/11/2025 02:19

** Tryptamine Therapeutic TYP.AX falls 2.6% to A$0.037; on track for steepest intraday pct decline since October 27

** Biotechnology co to raise A$6.1 million (~$4 million) at A$0.034/share

** Issue price represents 10.5% discount to last close on October 31, when trading was halted pending capital raise

** Stock sees busiest session since October 2024, with ~15.6 mln shares traded - 6.6x the 30-day average

** YTD, TYP falls 2.6%

($1 = A$1.5389)

 (Reporting by Jasmeen Ara Shaikh in Bengaluru)

 ((Jasmeenaraislam.shaikh@thomsonreuters.com))